Skip to main content
QMSQMS
QMS
  • Welcome to your QMS
  • Quality Manual
  • Procedures
  • Records
  • TF_Legit.Health_Plus
    • Legit.Health Plus TF index
    • Legit.Health Plus STED
    • Legit.Health Plus description and specifications
    • R-TF-001-007 Declaration of conformity
    • GSPR
    • Clinical
      • Evaluation
      • Investigation
        • 🗄 Drafts
          • R-TF-015-004 Clinical investigation plan_LEGIT_MX_EVCDAO_2020
          • R-TF-015-004 Clinical investigation plan_LEGIT_URT_EVCDAO_2020
          • R-TF-015-006 Clinical investigation report_LEGIT_MX_EVCDAO_2020
          • R-TF-015-006 Clinical investigation report_LEGIT_URT_EVCDAO_2020
        • BI 2024
        • COVIDX EVCDAO 2022
        • DAO Derivación O 2022
        • DAO Derivación PH 2022
        • IDEI 2023
        • MC EVCDAO 2019
        • PH 2024
        • SAN 2024
      • R-TF-015-008 Clinical development plan
    • Design and development
    • Design History File (DHF)
    • IFU and label
    • Post-Market Surveillance
    • Quality control
    • Risk Management
  • Licenses and accreditations
  • External documentation
  • TF_Legit.Health_Plus
  • Clinical
  • Investigation
  • 🗄 Drafts
  • R-TF-015-004 Clinical investigation plan_LEGIT_URT_EVCDAO_2020

R-TF-015-004 Clinical investigation plan_LEGIT_URT_EVCDAO_2020

Ethics committee approval

Record signature meaning​

  • Author: JD-004 María Diez
  • Reviewer: JD-003 Taig Mac Carthy
  • Approval: JD-005 Approver name
Previous
R-TF-015-004 Clinical investigation plan_LEGIT_MX_EVCDAO_2020
Next
R-TF-015-006 Clinical investigation report_LEGIT_MX_EVCDAO_2020
  • Record signature meaning
All the information contained in this QMS is confidential. The recipient agrees not to transmit or reproduce the information, neither by himself nor by third parties, through whichever means, without obtaining the prior written permission of Legit.Health (AI LABS GROUP S.L.)